FDA Adverse Event Injury Summary report: N

PROLENE POLYPROPYLENE MESH

MDR report key: 3222224 · Received July 12, 2013

Report

Report Number
2210968-2013-12659
Event Type
Injury
Date Received
July 12, 2013
Report Date
September 21, 2016
Manufacturer
ETHICON INC.
Product Code
FTL
PMA / PMN Number
K962530
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

DATE SENT TO THE FDA: 09/17/2013. CORRECTION: THE MANUFACTURING SITE HAS BEEN UPDATED.

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED UTI, ATROPHIC VAGINITIS AND URINARY FREQUENCY. IT WAS REPORTED THAT PATIENT CONCURRENTLY UNDERWENT PARAVAGINAL REPAIR WITH GRAFT AND POSTERIOR REPAIR WITH GRAFT.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2009 AND MESH WAS IMPLANTED. IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGOICAL PROCEDURE ON (B)(6) 2009 AND COLOPLAST TRANS-OBTURATOR TAPE AND COLOPLAST NOVASILK POLYPROPYLENE MESH WERE IMPLANTED, BUT NOT MARKED ON COMPLAINT. IT WAS REPORTED THAT SHE EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
324251 PROLENE POLYPROPYLENE MESH MESH, SURGICAL, POLYMERIC FTL ETHICON INC. UNK UPE019

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention